Xvivo Perfusion AB
STO:XVIVO
Xvivo Perfusion AB
Gross Profit
Xvivo Perfusion AB
Gross Profit Peer Comparison
Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors
Company | Gross Profit | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Xvivo Perfusion AB
STO:XVIVO
|
Gross Profit
kr475.4m
|
CAGR 3-Years
51%
|
CAGR 5-Years
27%
|
CAGR 10-Years
24%
|
|
Bactiguard Holding AB
STO:BACTI B
|
Gross Profit
kr126.8m
|
CAGR 3-Years
1%
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
See Also
What is Xvivo Perfusion AB's Gross Profit?
Gross Profit
475.4m
SEK
Based on the financial report for Mar 31, 2024, Xvivo Perfusion AB's Gross Profit amounts to 475.4m SEK.
What is Xvivo Perfusion AB's Gross Profit growth rate?
Gross Profit CAGR 10Y
24%
Over the last year, the Gross Profit growth was 41%. The average annual Gross Profit growth rates for Xvivo Perfusion AB have been 51% over the past three years , 27% over the past five years , and 24% over the past ten years .